Detalhe da pesquisa
1.
Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice.
Sci Rep
; 4: 4554, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24686534
2.
Febuxostat, an inhibitor of xanthine oxidase, suppresses lipopolysaccharide-induced MCP-1 production via MAPK phosphatase-1-mediated inactivation of JNK.
PLoS One
; 8(9): e75527, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24086554